The Chemours Company CC
$ 20.88
8.41%
Quarterly report 2024-Q3
added 11-04-2024
The Chemours Company Balance Sheet 2011-2024 | CC
Annual Balance Sheet The Chemours Company
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.84 B | 2.54 B | 2.33 B | 2.96 B | 3.22 B | 2.77 B | 2.56 B | 2.64 B | 3.59 B | - | - | - | - |
Long Term Debt |
3.99 B | 3.59 B | 3.72 B | 4 B | 4.03 B | 3.96 B | 4.1 B | 3.53 B | 3.92 B | - | - | - | - |
Long Term Debt Current |
55 M | 49 M | 59 M | 57 M | 66 M | 13 M | 15 M | 15 M | 39 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 5.02 B | 4.63 B | 4.78 B | 4.18 B | 4.7 B | 898 M | 871 M | 855 M | - |
Total Current Liabilities |
2.49 B | 1.89 B | 1.86 B | 1.44 B | 1.54 B | 1.71 B | 1.65 B | 1.77 B | 1.47 B | - | - | - | - |
Total Liabilities |
7.51 B | 6.53 B | 6.47 B | 6.27 B | 6.56 B | 6.34 B | 6.43 B | 5.96 B | 6.17 B | 2.3 B | 2.34 B | 2.09 B | - |
Deferred Revenue |
- | - | - | - | 7 M | 6 M | 8 M | 76 M | 20 M | 38 M | 32 M | 13 M | - |
Retained Earnings |
1.78 B | 2.17 B | 1.75 B | 1.3 B | 1.25 B | 1.47 B | 579 M | -114 M | -115 M | - | - | - | - |
Total Assets |
8.25 B | 7.64 B | 7.55 B | 7.08 B | 7.26 B | 7.36 B | 7.29 B | 6.06 B | 6.3 B | 5.98 B | 5.62 B | 5.32 B | - |
Cash and Cash Equivalents |
1.2 B | 1.1 B | 1.45 B | 1.1 B | 943 M | 1.2 B | 1.56 B | 902 M | 366 M | - | - | - | - |
Book Value |
739 M | 1.11 B | 1.08 B | 815 M | 695 M | 1.02 B | 865 M | 104 M | 130 M | 3.67 B | 3.28 B | 3.23 B | - |
Total Shareholders Equity |
737 M | 1.11 B | 1.08 B | 815 M | 689 M | 1.01 B | 860 M | 100 M | 126 M | 3.67 B | 3.22 B | - | - |
All numbers in USD currency
Quarterly Balance Sheet The Chemours Company
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
3.99 B | 3.95 B | 3.97 B | 3.99 B | 3.94 B | 3.6 B | 3.6 B | 3.59 B | 3.51 B | - | 3.69 B | 3.72 B | 3.83 B | 3.96 B | 3.97 B | 4 B | 4 B | 4 B | 4 B | 4.03 B | 4.03 B | 4.03 B | 4.03 B | 3.96 B | 3.96 B | 3.96 B | 3.96 B | 4.1 B | 4.1 B | 4.1 B | 4.1 B | 3.53 B | 3.53 B | 3.53 B | 3.53 B | 3.92 B | 3.92 B | 3.92 B | 3.92 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.8 B | 6.52 B | 7.22 B | 7.51 B | 7.19 B | 6.85 B | 6.4 B | 6.53 B | 6.46 B | - | 6.36 B | 6.47 B | 6.53 B | 6.58 B | 6.32 B | 6.27 B | 6.27 B | 6.27 B | 6.27 B | 6.56 B | 6.56 B | 6.56 B | 6.56 B | 6.34 B | 6.34 B | 6.34 B | 6.34 B | 6.43 B | 6.43 B | 6.43 B | 6.43 B | 5.96 B | 5.96 B | 5.96 B | 5.96 B | 6.17 B | 6.17 B | 6.17 B | 6.17 B | 2.29 B | 2.3 B | 2.3 B | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | 3 M | 2 M | 3 M | 5 M | 7 M | 7 M | 7 M | 7 M | 7 M | 8 M | 8 M | 7 M | 6 M | 6 M | 6 M | 6 M | 8 M | 8 M | 8 M | 8 M | 76 M | 76 M | 76 M | 76 M | 20 M | - | - | - | 28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
1.76 B | 1.83 B | 1.8 B | 1.78 B | 1.84 B | 1.86 B | 2.28 B | 2.17 B | 2.3 B | - | 1.94 B | 1.75 B | 1.55 B | 1.38 B | 1.36 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B | 1.25 B | 1.25 B | 1.25 B | 1.25 B | 1.47 B | 1.47 B | 1.47 B | 1.47 B | 579 M | 579 M | 579 M | 579 M | -114 M | -114 M | -114 M | -114 M | -115 M | -115 M | -115 M | -115 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
7.46 B | 7.25 B | 7.98 B | 8.25 B | 7.95 B | 7.66 B | 7.62 B | 7.64 B | 7.74 B | - | 7.52 B | 7.55 B | 7.53 B | 7.48 B | 7.17 B | 7.08 B | 7.08 B | 7.08 B | 7.08 B | 7.26 B | 7.26 B | 7.26 B | 7.26 B | 7.36 B | 7.36 B | 7.36 B | 7.36 B | 7.29 B | 7.29 B | 7.29 B | 7.29 B | 6.06 B | 6.06 B | 6.06 B | 6.06 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 5.96 B | 5.98 B | 5.98 B | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
596 M | 604 M | 746 M | 1.2 B | 1.45 B | 945 M | 1.02 B | 1.1 B | 1.37 B | 1.35 B | 1.24 B | 1.45 B | 1.13 B | 1.14 B | 1.01 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 943 M | 943 M | 943 M | 943 M | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.56 B | 1.56 B | 1.56 B | 1.56 B | 902 M | 902 M | 902 M | 902 M | 366 M | 366 M | 366 M | 366 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
659 M | 725 M | 754 M | 739 M | 757 M | 810 M | 1.23 B | 1.11 B | 1.28 B | - | 1.17 B | 1.08 B | 999 M | 900 M | 852 M | 815 M | 815 M | 815 M | 815 M | 695 M | 695 M | 695 M | 695 M | 1.02 B | 1.02 B | 1.02 B | 1.02 B | 865 M | 865 M | 865 M | 865 M | 104 M | 104 M | 104 M | 104 M | 130 M | 130 M | 130 M | 130 M | 3.67 B | 3.67 B | 3.67 B | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
657 M | 723 M | 752 M | 737 M | 749 M | 810 M | 1.23 B | 1.11 B | 1.28 B | 1.22 B | 1.17 B | 1.08 B | 999 M | 898 M | 850 M | 813 M | 813 M | 813 M | 813 M | 689 M | 689 M | 689 M | 689 M | 1.01 B | 1.01 B | 1.01 B | 1.01 B | 860 M | 860 M | 860 M | 860 M | 100 M | 100 M | 100 M | 100 M | 126 M | 126 M | 126 M | 126 M | 3.67 B | 3.67 B | 3.67 B | - | 3.22 B | - | - | - | 3.17 B | - | - | - | - | - | - | - |
All numbers in USD currency